Clinical Examinations: Mutual Understandings and Adequate Usage Suitable for a New Era. Topics: II. Tumor marker (cancer biomarker) update and its application.
1) Bando H, et al: A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer. Br J Cancer 120: 982-986, 2019.
2) Lennon AM, et al: Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention. Science 369: eabb9601, 2020.
3) Liu MC, et al: Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann Oncol 31: 745-759, 2020.
4) Godsey JH, et al: Generic protocols for the analytical validation of next-generation sequencing-based ctDNA assays: a joint consensus recommendation of the BloodPAC' s Analytical Variables Working Group. Clin Chem 66: 1156-1166, 2020.
5) Asakura K, et al: A miRNA-based diagnostic model predicts resectable lung cancer in humans with high accuracy. Commun Biol 3: 134, 2020.